For example, VEGF‐C156S treatment promotes cardiac lymphangiogenesis, which increases the clearance of inflammatory cells (myeloid cells, macrophages, and dendritic cells) and improves cardiac dysfunction in mice after MI in a LYVE‐1‐dependent manner.17, 18. The gene discussed is VEGFA; the disease is myocardial infarction.